A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

IsraelActive Not RecruitingPHASE2, PHASE3

Conditions

Relapsed/Refractory Diffuse Large B-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Chandler, Arizona, United States

  • Arizona Oncology Associates, Tucson, Arizona, United States

  • The Oncology Institute (TOI) Clinical Research, Cerritos, California, United States

  • Norton Cancer Institute, St. Matthews, Louisville, Kentucky, United States

  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States

  • Stony Brook, Stony Brook, New York, United States

  • Texas Oncology - Tyler, Tyler, Texas, United States

  • The University of Texas Health Science Center at Tyler DBA UT Health East Texas HOPE Cancer Center, Tyler, Texas, United States

  • Jiangsu Province Hospital, Nanjing, Jiangsu, China

  • The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

  • Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School, Huangpu, Shanghai Municipality, China

  • Zhongshan Hospital Fudan University, Xuhui, Shanghai Municipality, China

  • Huaxi Hospital Sichuan University, Chengdu, Sichuan, China

  • The first affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China

  • Assuta Ashdod Medical Center, Ashdod, Israel

  • Soroka Medical Center, Beersheba, Israel

  • Rabin Medical Center, Petah Tikva, Israel

  • Assuta medical centers - Ramat Hachayal, Tel Aviv, Israel

  • AOU Ospedali Riuniti-Università Politecnica delle Marche Clinica di Ematologia, Ancona, Ancona, Italy

  • UOC Ematologia ad Indirizzo Oncologico, AORN "Sant'Anna e San Sebastiano", Caserta, Caserta, Italy

  • National Cancer Institute, Naples, Napoli, Italy

  • AOU Maggiore della Carità SCDU Ematologia, Novara, Novara, Italy

  • DIP. Oncologia- Ematologia, UOSD Centro Diagnosie TerapiaDei Linfomi, Pescara, Pescara, Italy

  • Fondatione Policlinico Universitario A. Gemelli, Rome, Rome, Italy

  • Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Sicily, Italy

  • AOU City of Health and Science of Turin, Turin, Torino, Italy

  • Pratia MCM Krakow, Krakow, Lesser, Poland

  • Szpitale pomorskie gdynia dept of haematology, Gdynia, Pomeranian Voivodeship, Poland

  • Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku Uniwersytecki Szpital Kliniczny im. Jana Mikulicza - Radeckiego we Wrocławiu, Wroclaw, Radeckiego, Poland

  • Pratia Onkologia Katowice, Katowice, Silesian Voivodeship, Poland

  • CM Pratia Poznań, Skorzewo, Wielkopolska, Poland

  • Institute of Hematology and Transfusion Medicine, Warsaw, Poland

  • Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

  • Institut català d'oncologia-hospital germans trias i pujol, Badalona, Barcelona, Spain

  • Hospital Vall Hebron, Barcelona, Barcelona, Spain

  • Institut Catala D'oncolocia, Barcelona, Barcelona, Spain

  • Hospital Universitario La Paz, Madrid, Madrid, Spain

  • Hospital Virgen del Rocío, Seville, Seville, Spain